Cigarette makers defend menthol to U.S. FDA panel

	Tweet

Tobacco companies defended menthol cigarettes to a U.S. advisory panel on Wednesday as health advocates called for a government ban on the popular flavoring.

About 19 million Americans smoke menthol cigarettes. Health advocates say the flavor masks the harshness of tobacco, making it easier to start smoking and harder to quit.

Manufacturers told a Food and Drug Administration panel that adding menthol did not make a cigarette more harmful or addictive.

"Overall the weight of scientific evidence indicates menthol does not change the inherent health risks of cigarette smoking,” said James Dillard, a senior vice president at Altria, which sells menthol versions of its Marlboro brand cigarettes.

The panel of outside experts is studying the health effects of menthol and is due to submit a report by March 2011. The FDA eventually could ban menthol, although some activists and industry analysts doubt that will happen. Stronger warnings or advertising limits are other possibilities.

Any government action against menthol could be a blow to Lorillard, the nation’s third-largest cigarette company and maker of the top-selling menthol brand Newport.

A 2009 law that gave the FDA oversight of tobacco products banned other cigarette flavors such as chocolate, clove and fruit that could lure children. But Congress exempted menthol, the most popular flavoring with about 27 percent of the cigarette market, and instead called for an FDA review.

The issue is racially sensitive as blacks overwhelmingly favor menthol and suffer more from smoking-related illnesses and deaths than whites. A government survey showed 83 percent of adult black smokers chose menthol cigarettes.

The American Academy of Pediatrics and others urged a ban on menthol flavoring, telling the FDA panel that it appealed to young people.

“Menthol has become the industry’s last holdout and last hope for disguising the taste of tobacco… we should not allow companies to sweeten the poison,” said Brandel France de Bravo of the National Research Center for Women & Families, a consumer group.

R.J. Reynolds said there was no evidence the health risks of menthol were greater than regular cigarettes.

“There is no scientific basis to treat menthol cigarettes differently than regular cigarettes,” said Michael Ogden, an official with Reynolds American unit R.J. Reynolds, which markets menthol-flavored Camels.

Lorillard Senior Vice President Bill True said there was no data to show that youth smoking rates would drop if menthol cigarettes were no longer available.

The panel is set to meet again on the menthol issue in a few months.

---
By Lisa Richwine

WASHINGTON (Reuters)

RELATED STORIES:
U.S. launches giant study on children   UK could have best health system in world - US expert   Brain imaging studies examine how anti-smoking medications may curb cravings   Canada outranks U.S. in healthcare report card   N.C. Tobacco Prevention Programs Are Saving Lives and Money   Medicare a model for health system   Secondhand Smoke Exposure: Worldwide Concern   Improving Livestock Trade and Human Livelihoods in Africa   Doctors, nurses told to get flu vaccination   More than 200 Abused Children Under 5 Died in U.S. Hospitals in 2005   Genetic Factors in Smoking Also Increase Risk of Chronic Bronchitis   Effects on drinking differ by gender

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]